Dexamfetamine, a regulated substance, is administered in Australia primarily for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) and, less frequently , narcolepsy. The drug's application is strictly regulated under the Therapeutic Goods Act and requires a current prescription from a